The Global Alliance against Respiratory Diseases (GARD) Country Report.

[Global alliance against chronic respiratory diseases].

Hundreds of millions of people of all ages suffer from chronic respiratory diseases which include asthma and respiratory allergies, chronic obstructive pulmonary disease, occupational lung diseases and pulmonary hypertension. More than 500 million patients live in developing countries or in deprived populations. Chronic respiratory diseases are increasing in prevalence. Although the cost of ina...

[Global Alliance Against Chronic Respiratory Diseases (GARD)].

Conference: "COPD a social disease: inappropriateness and pharmaco-economics. The role of the specialist: present and future", Venice, April 21-22, 2010: long summaries

Long summaries / Riassunti estesi " COPD a social disease: inappropriateness and pharmaco-economics. Conference: "COPD a social disease: inappropriateness and pharmaco-economics. The role of the specialist: present and future", Chronic respiratory diseases (CRDs), with particular regard to COPD, constitute an epidemic in the full sense of the term, though they still go underdiag-nosed and under...

Global alliance against chronic respiratory diseases in Italy (GARD-Italy): strategy and activities.

The steady increase in incidence of chronic respiratory disease (CRD) now constitutes a serious public health problem. CRDs are often underdiagnosed and many patients are not diagnosed until the CRD is too severe to prevent normal daily activities. The prevention of CRDs and reducing their social and individual impacts means modifying environmental and social factors and improving diagnosis and...

Chronic respiratory diseases at primary health care level in Georgia: the results of the pilot study.

BACKGROUND AND AIM Millions of people suffer from chronic respiratory diseases (CRD). To address this serious global health problem WHO formed the Global Alliance against Chronic Respiratory Diseases (GARD). Chronic obstructive pulmonary disease (COPD) is a major priority of GARD due to high chronic morbidity and mortality; however, there is still little prevalence data available. The prevalenc...